IGF1 and prostate cancer: In our study, elevated levels of insulin and IGF-1 in the PCa-DM group are positively correlated with the prostate cancer grade and risk, supporting the hypothesis that the mitogenic and oncogenic roles of insulin and IGF-1 might be associated with cancer aggressiveness in the diabetic group.